FI972683L - Kemiallisia yhdisteitä - Google Patents
Kemiallisia yhdisteitä Download PDFInfo
- Publication number
- FI972683L FI972683L FI972683A FI972683A FI972683L FI 972683 L FI972683 L FI 972683L FI 972683 A FI972683 A FI 972683A FI 972683 A FI972683 A FI 972683A FI 972683 L FI972683 L FI 972683L
- Authority
- FI
- Finland
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426192.2A GB9426192D0 (en) | 1994-12-23 | 1994-12-23 | Chemical compounds |
| GBGB9516810.0A GB9516810D0 (en) | 1995-08-16 | 1995-08-16 | Chemical compounds |
| PCT/GB1995/002991 WO1996020011A1 (en) | 1994-12-23 | 1995-12-21 | Chemical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI972683A0 FI972683A0 (fi) | 1997-06-19 |
| FI972683A7 FI972683A7 (fi) | 1997-06-19 |
| FI972683L true FI972683L (fi) | 1997-06-19 |
Family
ID=26306259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI972683A FI972683L (fi) | 1994-12-23 | 1995-12-21 | Kemiallisia yhdisteitä |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5985281A (https=) |
| EP (1) | EP0806964B1 (https=) |
| JP (1) | JP3805365B2 (https=) |
| KR (1) | KR100270650B1 (https=) |
| CN (1) | CN1095677C (https=) |
| AT (1) | ATE222124T1 (https=) |
| AU (1) | AU701916B2 (https=) |
| BR (1) | BR9510490B1 (https=) |
| CA (1) | CA2205091A1 (https=) |
| CZ (1) | CZ195297A3 (https=) |
| DE (1) | DE69527805T2 (https=) |
| ES (1) | ES2181805T3 (https=) |
| FI (1) | FI972683L (https=) |
| HU (1) | HUT77450A (https=) |
| IL (1) | IL116511A0 (https=) |
| MX (1) | MX9704575A (https=) |
| NO (1) | NO972882L (https=) |
| NZ (1) | NZ297529A (https=) |
| PL (1) | PL184031B1 (https=) |
| RU (1) | RU2189251C2 (https=) |
| SK (1) | SK80997A3 (https=) |
| TR (1) | TR199501654A2 (https=) |
| WO (1) | WO1996020011A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1193278A (zh) | 1995-08-16 | 1998-09-16 | 曾尼卡有限公司 | 化合物 |
| SG71046A1 (en) | 1996-10-10 | 2000-03-21 | Connector Systems Tech Nv | High density connector and method of manufacture |
| AU6000698A (en) * | 1997-02-14 | 1998-09-08 | Zeneca Limited | Proteins |
| GB9703201D0 (en) * | 1997-02-15 | 1997-04-02 | Zeneca Ltd | Chemical compounds |
| GB9709421D0 (en) * | 1997-05-10 | 1997-07-02 | Zeneca Ltd | Chemical compounds |
| JP4616991B2 (ja) * | 1998-09-18 | 2011-01-19 | イミューノメディクス、インコーポレイテッド | 化学療法剤の標的特異的な毒性を増加させるための方法および組成物 |
| US6361774B1 (en) | 1999-09-17 | 2002-03-26 | Immunomedics, Inc. | Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug |
| US20040117863A1 (en) * | 1998-09-18 | 2004-06-17 | Edge Michael D. | Transgenically produced fusion proteins |
| EP1220864A4 (en) * | 1999-09-17 | 2003-05-21 | Genzyme Transgenics Corp | TRANSGENICALLY PRODUCED FUSION PROTEINS |
| US7067148B2 (en) | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| BR0316643A (pt) * | 2002-11-27 | 2005-10-11 | Gtc Biotherapeutics Inc | Anticorpos modificados estavelmente produzidos no leite e método de produzir os mesmos |
| US20080019905A9 (en) * | 2005-02-18 | 2008-01-24 | Strome Scott E | Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| KR20080068089A (ko) * | 2005-10-21 | 2008-07-22 | 지티씨바이오쎄라퓨틱스,인크. | 항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및사용 방법 |
| US20080031866A1 (en) * | 2006-06-20 | 2008-02-07 | Eichenbaum Gary M | Method for modulating the pharmacokinetics and metabolism of a therapeutic agent |
| WO2007149827A2 (en) * | 2006-06-20 | 2007-12-27 | Janssen Pharmaceutica, N.V. | Method for modulating the pharmacokinetics and metabolism of a therapeutic agent |
| EP2077991B1 (en) * | 2006-10-03 | 2014-02-26 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates |
| GB0709333D0 (en) * | 2007-05-15 | 2007-06-20 | Smart Targeting Ltd | Binding protein |
| WO2009134389A2 (en) * | 2008-05-01 | 2009-11-05 | Gtc Biotherapeutics, Inc. | An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| US10745492B1 (en) * | 2019-04-03 | 2020-08-18 | Ark Diagnostics, Inc. | Antibodies to symmetrically dimethylated arginine analytes and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8705477D0 (en) * | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| US4975278A (en) * | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| US5632990A (en) * | 1988-04-22 | 1997-05-27 | Cancer Research Campaign Tech. Ltd. | Treatment for tumors comprising conjugated antibody A5B7 and a prodrug |
| GB8809616D0 (en) * | 1988-04-22 | 1988-05-25 | Cancer Res Campaign Tech | Further improvements relating to drug delivery systems |
| AU648015B2 (en) * | 1989-01-23 | 1994-04-14 | Akzo N.V. | Site specific in-vivo activation of therapeutic drugs |
| US5433955A (en) * | 1989-01-23 | 1995-07-18 | Akzo N.V. | Site specific in vivo activation of therapeutic drugs |
| AU674137B2 (en) * | 1992-01-30 | 1996-12-12 | Genzyme Limited | Chiral synthesis with modified enzymes |
| GB9323429D0 (en) * | 1993-11-12 | 1994-01-05 | Wellcome Found | Therapy |
| US5389537A (en) * | 1994-01-21 | 1995-02-14 | Wisconsin Alumni Research Foundation | Nuclease having altered specificity |
-
1995
- 1995-12-21 RU RU97112396/14A patent/RU2189251C2/ru not_active IP Right Cessation
- 1995-12-21 JP JP52028496A patent/JP3805365B2/ja not_active Expired - Fee Related
- 1995-12-21 CZ CZ971952A patent/CZ195297A3/cs unknown
- 1995-12-21 ES ES95941214T patent/ES2181805T3/es not_active Expired - Lifetime
- 1995-12-21 DE DE69527805T patent/DE69527805T2/de not_active Expired - Lifetime
- 1995-12-21 US US08/860,882 patent/US5985281A/en not_active Expired - Lifetime
- 1995-12-21 AT AT95941214T patent/ATE222124T1/de not_active IP Right Cessation
- 1995-12-21 WO PCT/GB1995/002991 patent/WO1996020011A1/en not_active Ceased
- 1995-12-21 CN CN95196986A patent/CN1095677C/zh not_active Expired - Fee Related
- 1995-12-21 AU AU42697/96A patent/AU701916B2/en not_active Ceased
- 1995-12-21 CA CA002205091A patent/CA2205091A1/en not_active Abandoned
- 1995-12-21 BR BRPI9510490-9A patent/BR9510490B1/pt not_active IP Right Cessation
- 1995-12-21 HU HU9702280A patent/HUT77450A/hu unknown
- 1995-12-21 KR KR1019970704250A patent/KR100270650B1/ko not_active Expired - Fee Related
- 1995-12-21 NZ NZ297529A patent/NZ297529A/xx not_active IP Right Cessation
- 1995-12-21 MX MX9704575A patent/MX9704575A/es not_active IP Right Cessation
- 1995-12-21 PL PL95320964A patent/PL184031B1/pl not_active IP Right Cessation
- 1995-12-21 FI FI972683A patent/FI972683L/fi unknown
- 1995-12-21 EP EP95941214A patent/EP0806964B1/en not_active Expired - Lifetime
- 1995-12-21 SK SK809-97A patent/SK80997A3/sk unknown
- 1995-12-22 TR TR95/01654A patent/TR199501654A2/xx unknown
- 1995-12-22 IL IL11651195A patent/IL116511A0/xx not_active IP Right Cessation
-
1997
- 1997-06-20 NO NO972882A patent/NO972882L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3805365B2 (ja) | 2006-08-02 |
| RU2189251C2 (ru) | 2002-09-20 |
| IL116511A0 (en) | 1996-07-23 |
| HUT77450A (hu) | 1998-04-28 |
| CZ195297A3 (en) | 1997-12-17 |
| US5985281A (en) | 1999-11-16 |
| AU701916B2 (en) | 1999-02-11 |
| PL184031B1 (pl) | 2002-08-30 |
| JPH10511547A (ja) | 1998-11-10 |
| MX9704575A (es) | 1997-10-31 |
| NO972882D0 (no) | 1997-06-20 |
| FI972683A0 (fi) | 1997-06-19 |
| FI972683A7 (fi) | 1997-06-19 |
| KR100270650B1 (ko) | 2000-11-01 |
| PL320964A1 (en) | 1997-11-24 |
| TR199501654A2 (tr) | 1996-07-21 |
| NO972882L (no) | 1997-08-19 |
| ATE222124T1 (de) | 2002-08-15 |
| WO1996020011A1 (en) | 1996-07-04 |
| BR9510490B1 (pt) | 2010-10-05 |
| ES2181805T3 (es) | 2003-03-01 |
| CA2205091A1 (en) | 1996-07-04 |
| CN1095677C (zh) | 2002-12-11 |
| DE69527805D1 (de) | 2002-09-19 |
| BR9510490A (pt) | 1998-01-13 |
| TR199501654A3 (https=) | 1996-07-21 |
| NZ297529A (en) | 1999-07-29 |
| EP0806964B1 (en) | 2002-08-14 |
| CN1171054A (zh) | 1998-01-21 |
| DE69527805T2 (de) | 2003-04-24 |
| AU4269796A (en) | 1996-07-19 |
| SK80997A3 (en) | 1998-02-04 |
| EP0806964A1 (en) | 1997-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID15985A (id) | Senyawa kimia | |
| EE200000283A (et) | Keemilised ühendid | |
| EE200000284A (et) | Keemilised ühendid | |
| EE200000285A (et) | Keemilised ühendid | |
| DK0777671T3 (da) | Spiro-azabicykliske forbindelser | |
| FI971260A7 (fi) | 1-asyyli-4-alifatyyliaminopiperidiiniyhdisteet | |
| ID16345A (id) | Senyawa-senyawa heterosiklik | |
| FI972970L (fi) | Uusia yhdisteitä | |
| BR9509760A (pt) | Composto | |
| FI960519L (fi) | Uusia yhdisteitä | |
| FI944078A7 (fi) | Kemiallisia yhdisteitä | |
| FI955587A7 (fi) | Kemialliset yhdisteet | |
| FI972683A7 (fi) | Kemiallisia yhdisteitä | |
| IS4739A (is) | Efnasambönd | |
| FI970279A7 (fi) | Orgaanisia yhdisteitä | |
| NO974170D0 (no) | Polyazacykloalkan-forbindelser | |
| FI970151A0 (fi) | Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä | |
| DK100497A (da) | Kemisk forbindelse | |
| FI945907A0 (fi) | Kemiallisia yhdisteitä | |
| BR9509740A (pt) | Compostos 18-nor-vitamina d | |
| FI971971A7 (fi) | Pyridatsinokinoliiniyhdisteitä | |
| ITMI951259A0 (it) | Composti chimici | |
| SE9601370L (sv) | Kemisk förening | |
| SE9402170D0 (sv) | New compounds | |
| SE9402838D0 (sv) | New compounds |